Colon Cancer Panel 2

Description

(KRAS, NRAS, BRAF mutation analysis + Her2 amplification + MSI by IHC)

Tissue, NA, Fasting or Non Fasting: As suggested by doctor

Sample Required:

FFPE colorectal tumour tissue block OR fresh tissue in DCGL Preservative Solution at 2–8°C.

Test Time:

Biopsy-dependent. 8–12 working days.

Test Normal Range:

No fixed normal range.

What is the Test?

An expanded colorectal cancer panel evaluating **KRAS, NRAS, BRAF mutations**, **HER2 amplification**, and **MSI by IHC**.

Test Procedure:

Tumour tissue is processed for NGS mutation testing plus HER2 and MSI immunohistochemistry.

When to Take the Test:

When combined genomic and MSI/Her2 information is required for treatment planning.

Who Should Take This Test:

Patients with colorectal cancer being considered for anti-HER2 or immunotherapy-based regimens.

Precautions for Exceptional Cases (Pregnancy, etc.):

Pregnant individuals should notify doctor; ensure tumour content >10%.